Cutting edge: ABIN-1 protects against psoriasis by restricting MyD88 signals in dendritic cells

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 535-539

  Callahan, Joseph A ^a   Hammer, Gianna E ^a   Agelides, Alexander ^a   Duong, Bao H ^a   Oshima, Shigeru ^a   North, Jeffrey ^b   Advincula, Rommel ^a   Shifrin, Nataliya ^a   Truong, Hong An ^b   Paw, Jonathan ^b   Barrera, Julio ^a   DeFranco, Anthony ^a   Rosenblum, Michael D ^b   Malynn, Barbara A ^a   Ma, Averil ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A20 BINDING AND INHIBITOR OF IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 1; EMOLLIENT AGENT; GLYCOPROTEIN P 15095; IMIQUIMOD; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN ABIN1; PROTEIN TNIP1; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; FLOW CYTOMETRY; GENETIC ASSOCIATION; HOMEOSTASIS; HUMAN; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN SECRETION; PSORIASIS; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-23; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PSORIASIS; SIGNAL TRANSDUCTION; TH17 CELLS; TOLL-LIKE RECEPTOR 7;

EID: 84880092397     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203335     Document Type: Article

References (29)

1. Nestle, F. O., D. H. Kaplan, and J. Barker. 2009. Psoriasis. N. Engl. J. Med. 361: 496-509.
2. Capon, F., A. D. Burden, R. C. Trembath, and J. N. Barker. 2012. Psoriasis and other complex trait dermatoses: from loci to functional pathways. J. Invest. Dermatol. 132: 915-922.
3. Johnson-Huang, L. M., M. A. Lowes, and J. G. Krueger. 2012. Putting together the psoriasis puzzle: an update on developing targeted therapies. Dis. Model. Mech. 5: 423-433.
4. Tejasvi, T., P. E. Stuart, V. Chandran, J. J. Voorhees, D. D. Gladman, P. Rahman, J. T. Elder, and R. P. Nair. 2012. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. J. Invest. Dermatol. 132: 593-600.
5. Nair, R. P., K. C. Duffin, C. Helms, J. Ding, P. E. Stuart, D. Goldgar, J. E. Gudjonsson, Y. Li, T. Tejasvi, B. J. Feng, et al Collaborative Association Study of Psoriasis. 2009. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41: 199-204.
6. Strange, A., F. Capon, C. C. Spencer, J. Knight, M. E. Weale, M. H. Allen, A. Barton, G. Band, C. Bellenguez, J. G. Bergboer, et al; Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2. 2010. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42: 985-990.
7. Sun, L. D., H. Cheng, Z. X. Wang, A. P. Zhang, P. G. Wang, J. H. Xu, Q. X. Zhu, H. S. Zhou, E. Ellinghaus, F. R. Zhang, et al. 2010. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 42: 1005-1009.
8. Heyninck, K., D. De Valck, W. Vanden Berghe, W. Van Criekinge, R. Contreras, W. Fiers, G. Haegeman, and R. Beyaert. 1999. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J. Cell Biol. 145: 1471-1482. (Pubitemid 29310004)
9. Wullaert, A., B. Wielockx, S. Van Huffel, V. Bogaert, B. De Geest, P. Papeleu, P. Schotte, K. El Bakkouri, K. Heyninck, C. Libert, and R. Beyaert. 2005. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine- induced acute liver failure and lethality. Hepatology 42: 381-389. (Pubitemid 41061091)
10. Wagner, S., I. Carpentier, V. Rogov, M. Kreike, F. Ikeda, F. Löhr, C. J. Wu, J. D. Ashwell, V. Dötsch, I. Dikic, and R. Beyaert. 2008. Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins. Oncogene 27: 3739-3745. (Pubitemid 351912974)
11. Oshima, S., E. E. Turer, J. A. Callahan, S. Chai, R. Advincula, J. Barrera, N. Shifrin, B. Lee, T. S. Benedict Yen, T. Woo, et al. 2009. ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 457: 906-909.
12. Nanda, S. K., R. K. Venigalla, A. Ordureau, J. C. Patterson-Kane, D. W. Powell, R. Toth, J. S. Arthur, and P. Cohen. 2011. Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J. Exp. Med. 208: 1215-1228.
13. Mauro, C., F. Pacifico, A. Lavorgna, S. Mellone, A. Iannetti, R. Acquaviva, S. Formisano, P. Vito, and A. Leonardi. 2006. ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J. Biol. Chem. 281: 18482-18488. (Pubitemid 44035507)
14. Zhou, J., R. Wu, A. A. High, C. A. Slaughter, D. Finkelstein, J. E. Rehg, V. Redecke, and H. Häcker. 2011. A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease. Proc. Natl. Acad. Sci. USA 108: E998- E1006.
15. Steinman, R. M. 2012. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30: 1-22.
16. Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
17. Stranges, P. B., J. Watson, C. J. Cooper, C. M. Choisy-Rossi, A. C. Stonebraker, R. A. Beighton, H. Hartig, J. P. Sundberg, S. Servick, G. Kaufmann, et al. 2007. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26: 629-641. (Pubitemid 46756349)
18. Birnberg, T., L. Bar-On, A. Sapoznikov, M. L. Caton, L. Cervantes-Barragán, D. Makia, R. Krauthgamer, O. Brenner, B. Ludewig, D. Brockschnieder, et al. 2008. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 29: 986-997.
19. Ohnmacht, C., A. Pullner, S. B. King, I. Drexler, S. Meier, T. Brocker, and D. Voehringer. 2009. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206: 549-559.
20. Hammer, G. E., E. E. Turer, K. E. Taylor, C. J. Fang, R. Advincula, S. Oshima, J. Barrera, E. J. Huang, B. Hou, B. A. Malynn, et al. 2011. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat. Immunol. 12: 1184-1193.
21. Kool, M., G. van Loo, W. Waelput, S. De Prijck, F. Muskens, M. Sze, J. van Praet, F. Branco-Madeira, S. Janssens, B. Reizis, et al. 2011. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35: 82-96.
22. Nestle, F. O., P. Di Meglio, J. Z. Qin, and B. J. Nickoloff. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9: 679-691.
23. Hou, B., B. Reizis, and A. L. DeFranco. 2008. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29: 272-282.
24. van der Fits, L., S. Mourits, J. S. Voerman, M. Kant, L. Boon, J. D. Laman, F. Cornelissen, A. M. Mus, E. Florencia, E. P. Prens, and E. Lubberts. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182: 5836-5845.
25. Cantisani, C., T. Lazic, A. G. Richetta, R. Clerico, C. Mattozzi, and S. Calvieri. 2012. Imiquimod 5% cream use in dermatology, side effects and recent patents. Recent Pat. Inflamm. Allergy Drug Discov. 6: 65-69.
26. - dendritic cells in the spleen. J. Exp. Med. 204: 1653-1664.
27. Fanti, P. A., E. Dika, S. Vaccari, C. Miscial, and C. Varotti. 2006. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int. J. Dermatol. 45: 1464-1465. (Pubitemid 44869771)
28. Cai, Y., X. Shen, C. Ding, C. Qi, K. Li, X. Li, V. R. Jala, H. G. Zhang, T. Wang, J. Zheng, and J. Yan. 2011. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 35: 596-610.
29. + innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122: 2252-2256.